- Home
- IMA vs PCM Comparison
IMA vs PCM Comparison
Compare IMA & PCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMA
- PCM
- Stock Information
- Founded
- IMA 2019
- PCM 1993
- Country
- IMA United States
- PCM United States
- Employees
- IMA N/A
- PCM N/A
- Industry
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- PCM Trusts Except Educational Religious and Charitable
- Sector
- IMA Health Care
- PCM Finance
- Exchange
- IMA Nasdaq
- PCM Nasdaq
- Market Cap
- IMA 92.2M
- PCM 82.0M
- IPO Year
- IMA N/A
- PCM N/A
- Fundamental
- Price
- IMA $8.23
- PCM $6.23
- Analyst Decision
- IMA Buy
- PCM
- Analyst Count
- IMA 1
- PCM 0
- Target Price
- IMA $30.00
- PCM N/A
- AVG Volume (30 Days)
- IMA 68.3K
- PCM 29.1K
- Earning Date
- IMA 11-12-2025
- PCM 01-01-0001
- Dividend Yield
- IMA N/A
- PCM 11.68%
- EPS Growth
- IMA N/A
- PCM N/A
- EPS
- IMA N/A
- PCM N/A
- Revenue
- IMA $800,000.00
- PCM N/A
- Revenue This Year
- IMA N/A
- PCM N/A
- Revenue Next Year
- IMA N/A
- PCM N/A
- P/E Ratio
- IMA N/A
- PCM N/A
- Revenue Growth
- IMA N/A
- PCM N/A
- 52 Week Low
- IMA $7.24
- PCM $6.88
- 52 Week High
- IMA $23.28
- PCM $10.20
- Technical
- Relative Strength Index (RSI)
- IMA N/A
- PCM 35.95
- Support Level
- IMA N/A
- PCM $6.25
- Resistance Level
- IMA N/A
- PCM $6.39
- Average True Range (ATR)
- IMA 0.00
- PCM 0.07
- MACD
- IMA 0.00
- PCM 0.01
- Stochastic Oscillator
- IMA 0.00
- PCM 5.56
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.
About PCM PCM Fund Inc.
Pcm Fund Inc is a closed-end investment management company. Its investment objective is to seek current income as a primary focus and also capital appreciation. The Fund invests in agency-guaranteed mortgage-backed securities, private-label mortgage-backed securities, high-yield corporate debt securities, and commercial mortgage-backed securities.